Responsible Officer: Derrick Araneda | Registered Since 2025
Eli Lilly and Company is one of the world’s largest research-based pharmaceutical companies. Their Canadian affiliate was founded in 1938 as a result of a collaboration between Eli Lilly and Company and Banting and Best, which produced the world’s first commercially available insulin. Lilly's work has broadened, and they now focus on diabetes, cancer, immunology, pain and neurodegeneration. Their products save and improve lives. Pharmaceuticals also save overall health care costs by improving health outcomes, reducing the need for surgeries, hospitalization, and extended care, and allowing people to return to work sooner. Lilly employees work to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to our communities through philanthropy and volunteerism. They employ approximately 325 people across Canada.
Registration Number: CL4419-20240725032545
Region: Ontario
Address: Exchange Tower, 130 King St W Suite 900, Toronto, ON, M5X 1B1, Canada